90 related articles for article (PubMed ID: 8390164)
21. Identification of a specific mammalian melanocortin receptor antagonist.
Tatro JB; Entwistle ML
Ann N Y Acad Sci; 1994 Oct; 739():315-9. PubMed ID: 7832484
[No Abstract] [Full Text] [Related]
22. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.
Siegrist W; Solca F; Stutz S; Giuffrè L; Carrel S; Girard J; Eberle AN
Cancer Res; 1989 Nov; 49(22):6352-8. PubMed ID: 2804981
[TBL] [Abstract][Full Text] [Related]
23. Biologically active monoiodinated alpha-MSH derivatives for receptor binding studies using human melanoma cells.
Eberle AN; Verin VJ; Solca F; Siegrist W; Küenlin C; Bagutti C; Stutz S; Girard J
J Recept Res; 1991; 11(1-4):311-22. PubMed ID: 1653337
[TBL] [Abstract][Full Text] [Related]
24. alpha-MSH receptor autoradiography on mouse and human melanoma tissue sections and biopsies.
Bagutti C; Oestreicher M; Siegrist W; Oberholzer M; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):427-42. PubMed ID: 8903955
[TBL] [Abstract][Full Text] [Related]
25. Radioreceptor assay for alpha-MSH using mouse B16 melanoma cells+.
Siegrist W; Oestreicher M; Stutz S; Girard J; Eberle AN
J Recept Res; 1988; 8(1-4):323-43. PubMed ID: 2838620
[TBL] [Abstract][Full Text] [Related]
26. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
27. Partial characterization of IR-alpha-MSH peptides found in melanoma tumors.
Ghanem G; Loir B; Hadley M; Abdel Malek Z; Libert A; Del Marmol V; Lejeune F; Lozano J; García-Borron JC
Peptides; 1992; 13(5):989-94. PubMed ID: 1336193
[TBL] [Abstract][Full Text] [Related]
28. Distribution of melanocortin receptors in the lower brainstem of the rat.
Tatro JB; Entwistle ML
Ann N Y Acad Sci; 1994 Oct; 739():311-4. PubMed ID: 7832483
[No Abstract] [Full Text] [Related]
29. Identification and characterization of melanotropin binding proteins from M2R melanoma cells by covalent photoaffinity labeling.
Gerst JE; Sole J; Hazum E; Salomon Y
Endocrinology; 1988 Oct; 123(4):1792-7. PubMed ID: 3416815
[TBL] [Abstract][Full Text] [Related]
30. Influence of alpha-MSH terminal amino acids on binding affinity and biological activity in melanoma cells.
Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
Peptides; 1994; 15(3):441-6. PubMed ID: 7937316
[TBL] [Abstract][Full Text] [Related]
31. Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells.
Ghanem GE; Comunale G; Libert A; Vercammen-Grandjean A; Lejeune FJ
Int J Cancer; 1988 Feb; 41(2):248-55. PubMed ID: 2828246
[TBL] [Abstract][Full Text] [Related]
32. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of gene delivery by an analogue of alpha-MSH in a receptor-independent fashion.
Chluba J; Lima de Souza D; Frisch B; Schuber F
Biochim Biophys Acta; 2001 Feb; 1510(1-2):198-208. PubMed ID: 11342158
[TBL] [Abstract][Full Text] [Related]
34. Peptides containing multiple photolabels: a new tool for the analysis of ligand-receptor interactions. Reversible long-lasting stimulation and inhibition of MSH receptors by multiple photocrosslinks with alpha-MSH.
Eberle AN
J Recept Res; 1993; 13(1-4):27-37. PubMed ID: 8383756
[TBL] [Abstract][Full Text] [Related]
35. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells.
Lyson K; Ceriani G; Takashima A; Catania A; Lipton JM
Neuroimmunomodulation; 1994; 1(2):121-6. PubMed ID: 7489322
[TBL] [Abstract][Full Text] [Related]
36. Evidence for alternate points of attachment for alpha-MSH and its stereoisomer [Nle4, D-Phe7]-alpha-MSH at the melanocortin-1 receptor.
Frändberg PA; Muceniece R; Prusis P; Wikberg J; Chhajlani V
Biochem Biophys Res Commun; 1994 Aug; 202(3):1266-71. PubMed ID: 8060302
[TBL] [Abstract][Full Text] [Related]
37. MSH receptors and the response of human A375 melanoma cells to interleukin-1 beta.
Baumann JB; Bagutti C; Siegrist W; Christen E; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):199-210. PubMed ID: 9029491
[TBL] [Abstract][Full Text] [Related]
38. Pre- and postnatal ontogeny of [125I]Nle4,D-Phe7-alpha-MSH binding sites in rat brain.
Lichtensteiger W; Hanimann B; Schlumpf M; Siegrist W; Eberle AN
Ann N Y Acad Sci; 1993 May; 680():652-4. PubMed ID: 8390210
[No Abstract] [Full Text] [Related]
39. Attempts to use alpha-melanotropin-containing melphalan in melanoma patients.
Lejeune FJ; Ghanem GE
Ann N Y Acad Sci; 1993 May; 680():391-400. PubMed ID: 8390159
[No Abstract] [Full Text] [Related]
40. Synthesis and biological properties of a biotinylated derivative of ACTH1-17 for MSH receptor studies.
Bagutti C; Eberle AN
J Recept Res; 1993; 13(1-4):229-44. PubMed ID: 8383754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
